GHGA Lecture Series: Peter Goodhand (virtual)

Peter Goodhand from the Global Alliance for Genomics and Health (GA4GH) talked about „Setting standards and frames policies to expand genomic data use within a human rights framework“ at the GHGA lecture series ("Advances in Data-Driven Biomedicine") on November 8, 2023.

Watch this lecture here.


Peter Goodhand is a leader in the global health sector, holding senior executive and board member positions in the health research advancement community

He currently serves as the Chief Executive Officer of the Global Alliance for Genomics in health (GA4GH) and President of GA4GH Inc. The Global Alliance for Genomics and Health (GA4GH) is a policy-framing and technical standards-setting organization, seeking to enable responsible genomic data sharing within a human rights framework. Mr. Goodhand played a critical role in the inception and development phase of the GA4GH as the Executive Director, prior to becoming the CEO. Mr. Goodhand is responsible and accountable for moving forward the GA4GH agenda, identifying and prioritizing objectives and outcomes that align with the overall GA4GH mission. In 2020, GA4GH Inc. was incorporated as a non-profit organization to scale its operations to reliably produce and protect technical standards and policy frameworks, create formal agreements with other international Standards organizations  and secure long term engagement from the international genomics community.

Mr. Goodhand previously served as President of the Ontario Institute for Cancer Research (OICR) and President and CEO of the Canadian Cancer Society. Before joining the charitable sector, he had a 20 year career in the global medical technology industry, including strategic leadership roles with multinational healthcare companies and as the founding Managing Director of the Health Technology Exchange (HTX).

Mr. Goodhand is currently Co-Chair of the International 100K+ Cohorts Consortium (IHCC), and serves on the governance boards of the Global Genomic Medicine Collaborative (GGMC), Global Genes, and on several national and international advisory bodies.

Mr. Goodhand also had a 12-year experience as a patient advocate, caregiver and navigator throughout his family’s battle with a rare cancer.